Aperio Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$41.5M Sell
175,611
-11,264
-6% -$2.66M 0.12% 161
2020
Q3
$50.9M Sell
186,875
-7,162
-4% -$1.95M 0.17% 108
2020
Q2
$56.3M Buy
194,037
+19,489
+11% +$5.66M 0.21% 90
2020
Q1
$41.5M Buy
174,548
+30,852
+21% +$7.34M 0.18% 109
2019
Q4
$31.5M Buy
143,696
+5,705
+4% +$1.25M 0.11% 197
2019
Q3
$23.4M Buy
137,991
+10,103
+8% +$1.71M 0.09% 246
2019
Q2
$23.5M Sell
127,888
-16,633
-12% -$3.05M 0.1% 243
2019
Q1
$26.6M Buy
144,521
+16,805
+13% +$3.09M 0.11% 198
2018
Q4
$21.2M Buy
127,716
+8,918
+8% +$1.48M 0.11% 221
2018
Q3
$22.9M Buy
118,798
+8,018
+7% +$1.55M 0.1% 226
2018
Q2
$18.8M Buy
110,780
+2,203
+2% +$374K 0.09% 256
2018
Q1
$17.7M Buy
108,577
+8,246
+8% +$1.34M 0.09% 267
2017
Q4
$15M Buy
100,331
+6,546
+7% +$981K 0.08% 303
2017
Q3
$14.3M Buy
93,785
+9,294
+11% +$1.41M 0.08% 297
2017
Q2
$10.9M Buy
84,491
+15,777
+23% +$2.03M 0.07% 354
2017
Q1
$7.51M Sell
68,714
-1,119
-2% -$122K 0.05% 420
2016
Q4
$5.15M Sell
69,833
-25,865
-27% -$1.91M 0.04% 493
2016
Q3
$8.35M Buy
95,698
+14,934
+18% +$1.3M 0.06% 367
2016
Q2
$6.95M Buy
80,764
+12,255
+18% +$1.05M 0.05% 403
2016
Q1
$5.45M Sell
68,509
-2,303
-3% -$183K 0.05% 447
2015
Q4
$8.91M Buy
70,812
+2,651
+4% +$334K 0.08% 282
2015
Q3
$7.1M Buy
68,161
+8,207
+14% +$855K 0.07% 324
2015
Q2
$7.4M Buy
59,954
+7,576
+14% +$935K 0.08% 306
2015
Q1
$6.18M Buy
52,378
+4,629
+10% +$546K 0.07% 347
2014
Q4
$5.67M Buy
47,749
+6,908
+17% +$821K 0.07% 348
2014
Q3
$4.59M Buy
40,841
+9,137
+29% +$1.03M 0.06% 374
2014
Q2
$3M Buy
31,704
+6,294
+25% +$596K 0.04% 483
2014
Q1
$1.8M Buy
+25,410
New +$1.8M 0.03% 737
2013
Q4
Sell
-20,370
Closed -$1.54M 771
2013
Q3
$1.54M Buy
20,370
+4,380
+27% +$332K 0.03% 678
2013
Q2
$1.28M Buy
+15,990
New +$1.28M 0.03% 662